Attitude towards antipsychotics among out-patients with schizophrenia in Nigeria

Acta Psychiatrica Scandinavica

Volumn 113, Issue 3, 2006, Pages 207-211

  Adewuya, A O ^a   Ola, B A ^a   Mosaku, S K ^a   Fatoye, F O ^a   Eegunranti, A B ^a  

^a OBAFEMI AWOLOWO UNIVERSITY TEACHING HOSPITALS COMPLEX   (Nigeria)

Author keywords

Antipsychotic medication; Attitude; Schizophrenia; Side effects

Indexed keywords

CHLORPROMAZINE; HALOPERIDOL; NEUROLEPTIC AGENT; THIORIDAZINE; TRIFLUOPERAZINE;

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DYSKINESIA; EMPLOYMENT; ERECTILE DYSFUNCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PARKINSONISM; PATIENT ATTITUDE; PRIORITY JOURNAL; SALIVATION DISORDER; SCHIZOPHRENIA; SEDATION; SIDE EFFECT; SYMPTOM;

ADULT; AMBULATORY CARE; ANTIPSYCHOTIC AGENTS; ATTITUDE TO HEALTH; CULTURE; DEMOGRAPHY; FEMALE; HUMANS; MALE; NIGERIA; QUESTIONNAIRES; SCHIZOPHRENIA;

EID: 33644758633     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2005.00745.x     Document Type: Article

References (39)

1. D avis JM. Overview: maintenance therapy in psychiatry 1: schizophrenia Am J Psychiatry 1975 132 1237 1245
2. K ane JM. Problems of compliance in the outpatient treatment of schizophrenia J Clin Psychiatry 1983 44 3 6
3. C abeza IG D iaz SEI A mador MS R odriguez GM G onzalez de C havez M. Factors related to treatment adherence in schizophrenic patients Acta Esp Psiquiatr 1999 27 211 216 (in Spanish)
4. H ofer A K emmler G E der U E dlinger M H ummer M F leischhacker WW. Quality of life in schizophrenia: the impact of psychopathology, attitude towards medication and side effects J Clin Psychiatry 2004 65 932 939
5. C ramer JA R osenheck R. Compliance with medication regimens for mental and physical disorders Psychiatr Serv 1998 49 196 201
6. M isdrahi D L lorca PM L ancon C B ayle FJ. Compliance in schizophrenia: predictive factors, therapeutical considerations and research implications Encephale 2002 28 266 272 (in French)
7. A dams SG H owe JT. Predicting medication compliance in a psychotic population J Nerv Ment Dis 1993 181 558 560
8. N aber D K arow A L ambert M Subjective well-being under neuroleptics treatment and its relevance to compliance Acta Psychiatr Scand 2005 111 232 243
9. B uchanan A. A two year prospective study of treatment compliance in patients with schizophrenia Psychol Med 1992 22 787 797
10. W eiden P P apkin B M ott T et al. Rating of medication influences (ROMI) scale in schizophrenia Schizophr Bull 1994 20 297 310
11. N aber D. Subjective effects of antipsychotic treatment Acta Psychiatr Scand 2005 111 81 83
12. D roulout T L iraud F V erdoux H. Relationships between insight and medication adherence in subjects with psychosis Encephale 2003 29 430 437 (in French)
13. F reudenreich O C ather C E vins AE H enderson DC G off DC. Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight J Clin Psychiatry 2004 65 1372 1376
14. G erlach J L arsen EB. Subjective experience and mental side effects of antipsychotic treatment Acta Psychiatr Scand 1999 99 suppl. 395 113 117
15. S ajatovic M R osch DS S ivec HJ et al. Insight into illness and attitudes toward medications among inpatients with schizophrenia Psychiatr Serv 2002 53 1319 1321
16. D ixon L W eiden P T orres M L ehman AM. Assertive community treatment and medication compliance in the homeless mentally ill Am J Psychiatry 1997 154 1302 1304
17. H ofer A K emmler G E der U H oneder M H ummer M F leischhacker WW. Attitudes toward antipsychotics among outpatient clinic attendees with schizophrenia J Clin Psychiatry 2002 63 49 53
18. A wad GA. Subjective response to neuroleptics in schizophrenia Schizophr Bull 1993 19 609 618
19. F leischhacker WW M eise U G unther V K urz M. Compliance with antipsychotics drug treatment: influence of side effects Acta Psychiatr Scand 1994 89 suppl. 382 11 15
20. K emp R H ayward P A pplewhaite G E veritt B D avid A. Compliance therapy in psychotic patients: a randomised controlled trial Br Med J 1996 312 345 349
21. D older CR L acro JP D unn LB J este DV. Antipsychotic medication adherence: is there a difference between typical and atypical agents Am J Psychiatry 2002 159 103 108
22. K ilian R D ietrich S T oumi M A ngermayer MC. Quality of life in persons with schizophrenia in out-patient treatment with first or second generation antipsychotics Acta Psychiatr Scand 2004 110 108 118
23. K arow A N aber D. Subjective well-being and quality of life under atypical antipsychotic treatment Psychopharmacology (Berl) 2002 162 3 10
24. O dejide AO. The prevalence of persistent abnormal movements among patients in a Nigerian long stay psychiatric unit Afr J Med Sci 1981 10 39 43
25. A mador XF F laum M A ndreason NC et al. Awareness of illness in schizophrenia and schizoaffective and mood disorders Arc Gen Psychiatry 1994 51 826 836
26. K ay SR F izbein A O pler LA. The positive and negative syndrome scale (PANSS) for schizophrenia Schizophr Bull 1987 13 261 276
27. G erlach J K orsgaard S C lemmesen P. et al. The St Hans Rating Scale for extrapyramidal side effects: reliability and validity Acta Psychiatr Scand 1993 87 244 252
28. L ingjaerde O A hlfors UG B ech P D encker SJ E lgen K. The UKU side effect rating scale: a new comprehensive rating scale for psychotropic drugs and a cross sectional study of side effects in neuroleptics-treated patients Acta Psychiatr Scand 1987 334 1 100
29. H ogan TP A wad AG E astwood R. A self report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity Psychol Med 1983 13 177 178
30. K ane JM. Compliance issues in outpatient treatment J Clin Psychopharmacol 1985 5 suppl. 3 22S 27S
31. K issling W. Compliance, quality assurance and standards for relapse prevention in schizophrenia Acta Psychiatr Scand 1994 89 suppl. 382 16 24
32. V an P utten T M ay PRA M arder SR W ittmann LA. Subjective response to antipsychotic drugs Arch Gen Psychiatry 1981 38 187 190
33. H ogan TP A wad AG. Subjective response to neuroleptics and outcome in schizophrenia: a re-examination comparing two measures Psychol Med 1992 22 347 352
34. B udd R H ughes I S mith J. Health beliefs and compliance with antipsychotic medication Br J Clin Psychol 1996 35 393 397
35. W yatt RJ. Neuroleptics and the natural course of schizophrenia Schizophr Bull 1991 17 325 351
36. M arder SR M ebane A C hien CP W inslade WJ S wann E V an P utten T. A comparison of patients who refused and consent to neuroleptics treatment Am J Psychiatry 1983 140 470 472
37. G aebel W P ietzcker A. One year outcome of schizophrenic patients: the interaction of chronicity and neuroleptics treatment Pharmacopsychiatry 1985 18 235 239
38. F amuyiwa OO. Psychotropic drug prescription in Nigeria Acta Psychiatr Scand 1983 68 73 81
39. A debowale TO O gunlesi AO. Beliefs and knowledge about aetiology of mental illness among Nigerian psychiatric patients and their relatives Afr J Med Med Sci 1999 28 35 41